High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations
ABSTRACT In the second antibody modeling assessment, we used a semiautomated template‐based structure modeling approach for 11 blinded antibody variable region (Fv) targets. The structural modeling method involved several steps, including template selection for framework and canonical structures of...
Saved in:
Published in | Proteins, structure, function, and bioinformatics Vol. 82; no. 8; pp. 1624 - 1635 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.08.2014
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ABSTRACT
In the second antibody modeling assessment, we used a semiautomated template‐based structure modeling approach for 11 blinded antibody variable region (Fv) targets. The structural modeling method involved several steps, including template selection for framework and canonical structures of complementary determining regions (CDRs), homology modeling, energy minimization, and expert inspection. The submitted models for Fv modeling in Stage 1 had the lowest average backbone root mean square deviation (RMSD) (1.06 Å). Comparison to crystal structures showed the most accurate Fv models were generated for 4 out of 11 targets. We found that the successful modeling in Stage 1 mainly was due to expert‐guided template selection for CDRs, especially for CDR‐H3, based on our previously proposed empirical method (H3‐rules) and the use of position specific scoring matrix‐based scoring. Loop refinement using fragment assembly and multicanonical molecular dynamics (McMD) was applied to CDR‐H3 loop modeling in Stage 2. Fragment assembly and McMD produced putative structural ensembles with low free energy values that were scored based on the OSCAR all‐atom force field and conformation density in principal component analysis space, respectively, as well as the degree of consensus between the two sampling methods. The quality of 8 out of 10 targets improved as compared with Stage 1. For 4 out of 10 Stage‐2 targets, our method generated top‐scoring models with RMSD values of less than 1 Å. In this article, we discuss the strengths and weaknesses of our approach as well as possible directions for improvement to generate better predictions in the future. Proteins 2014; 82:1624–1635. © 2014 Wiley Periodicals, Inc. |
---|---|
Bibliography: | istex:B884785E133D88260F076C3A74C5DD8DC37A51A4 ArticleID:PROT24591 ark:/67375/WNG-2VR5ZSKR-R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0887-3585 1097-0134 |
DOI: | 10.1002/prot.24591 |